Here's the live share price of Supriya Lifescience along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Supriya Lifescience has gained 10.63% CAGR. Over the past year, the corresponding return has been 3.07%.
Supriya Lifescience’s current P/E of 29.24x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Supriya Lifescience | -0.71 | -1.22 | -6.21 | 8.18 | 3.84 | 23.08 | 10.63 |
Sun Pharmaceutical Industries | 0.97 | -1.80 | -4.65 | -4.38 | -13.15 | 21.98 | 26.56 |
Divi's Laboratories | 0.07 | -1.47 | -9.84 | 7.01 | 9.43 | 17.82 | 13.69 |
Cipla | 1.32 | 0.77 | 4.54 | 7.68 | -5.15 | 13.91 | 16.87 |
Torrent Pharmaceuticals | -0.56 | -1.60 | 9.51 | 16.40 | 3.02 | 33.17 | 20.55 |
Dr. Reddy's Laboratories | 3.77 | 5.10 | -3.31 | 18.82 | -1.15 | 15.58 | 8.56 |
Mankind Pharma | 1.25 | 4.79 | 8.46 | 17.37 | 3.39 | 21.96 | 12.65 |
Zydus Lifesciences | 3.03 | 5.64 | 7.16 | 18.39 | -6.58 | 40.52 | 23.17 |
Lupin | 5.05 | 2.70 | 2.13 | 3.75 | -9.35 | 44.90 | 16.11 |
Abbott India | -0.30 | -5.76 | -1.46 | 4.98 | 5.15 | 19.70 | 13.47 |
Alkem Laboratories | 1.96 | 0.93 | 12.23 | 15.67 | -14.48 | 19.30 | 13.34 |
Aurobindo Pharma | 4.78 | 1.59 | -4.90 | -0.03 | -30.19 | 25.70 | 6.59 |
Glenmark Pharmaceuticals | 3.46 | 4.57 | 27.25 | 51.30 | 21.25 | 75.97 | 34.52 |
Biocon | 0.26 | 1.26 | 2.62 | 12.96 | -3.71 | 6.33 | -3.24 |
Laurus Labs | 1.70 | 3.77 | 34.34 | 56.25 | 77.18 | 17.90 | 27.44 |
GlaxoSmithKline Pharmaceuticals | 0.17 | 0.05 | -15.89 | 4.42 | -4.41 | 24.98 | 9.94 |
Anthem Biosciences | 0.28 | 10.26 | 13.93 | 13.93 | 13.93 | 4.44 | 2.64 |
Cohance Lifesciences | 5.60 | -1.14 | -2.90 | -14.86 | -19.22 | 26.94 | 21.87 |
Ipca Laboratories | -1.62 | -3.70 | -3.91 | 1.17 | -11.01 | 14.50 | 4.09 |
Gland Pharma | 6.68 | 3.57 | 19.57 | 29.97 | 7.58 | -5.10 | 2.10 |
Over the last one year, Supriya Lifescience has gained 3.84% compared to peers like Sun Pharmaceutical Industries (-13.15%), Divi's Laboratories (9.43%), Cipla (-5.15%). From a 5 year perspective, Supriya Lifescience has underperformed peers relative to Sun Pharmaceutical Industries (26.56%) and Divi's Laboratories (13.69%).
Day | SMA | EMA |
---|---|---|
5 | 653.98 | 654.46 |
10 | 656.19 | 656.54 |
20 | 661.86 | 660.75 |
50 | 680.26 | 671.67 |
100 | 685.26 | 677.96 |
200 | 696.87 | 658.32 |
In the latest quarter, Supriya Lifescience remained same as its previous close in promoter holding, while DII stake increased to 4.86%, FII holding fell to 6.78%, and public shareholding moved down to 20.08% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
ITI ELSS Tax Saver Fund | 91,519 | 1.44 | 6.05 |
ITI Pharma and Healthcare Fund | 36,815 | 1.03 | 2.43 |
Motilal Oswal BSE Healthcare ETF | 601 | 0.12 | 0.04 |
Date Time | Announcement |
---|---|
Sep 02, 2025, 7:55 PM IST | Supriya Lifescience - Intimation Under Regulation 30 Regarding Letter Dispatched To The Shareholders Of The Company Providing |
Sep 02, 2025, 12:58 AM IST | Supriya Lifescience - Business Responsibility and Sustainability Reporting (BRSR) |
Sep 02, 2025, 12:48 AM IST | Supriya Lifescience - Reg. 34 (1) Annual Report. |
Sep 02, 2025, 12:36 AM IST | Supriya Lifescience - Notice Of 17Th Annual General Meeting Of Members Of The Company Scheduled To Be Held On Wednesday, Sept |
Aug 30, 2025, 10:55 PM IST | Supriya Lifescience - Intimation Of Record Date For 17Th AGM Of The Company Scheduled On September 24, 2025. |
Supriya Lifescience Ltd. is a Public Limited Listed company incorporated on 26/03/2008 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L51900MH2008PLC180452 and registration number is 180452. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 696.49 Cr. and Equity Capital is Rs. 16.10 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Supriya Lifescience is ₹647.00 as on Sep 12, 2025.
The Supriya Lifescience is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Supriya Lifescience is ₹5,207.24 Cr as on Sep 12, 2025.
Today’s highest and lowest price of Supriya Lifescience are ₹654.65 and ₹645.20.
The 52-week high/low is the highest and lowest price at which Supriya Lifescience stock has traded in the past 52-week or nearly a year. The 52-week high of Supriya Lifescience is ₹841.70 and 52-week low of Supriya Lifescience is ₹511.45 as on Sep 12, 2025.
The Supriya Lifescience has shown returns of -0.92% over the past day, -0.75% for the past month, -7.56% over 3 months, 3.07% over 1 year, 23.08% across 3 years, and 10.63% over 5 years.
P/E ratio of and PB ratio of Supriya Lifescience are 29.24 and 5.75 on Sep 12, 2025. While the company gives a dividend yield of 0.00 per annum.